Martins Cristiano, Sayegh Souheil, Faundez Antonio, Fourchet François, Bothorel Hugo
Physiotherapy Department and Motion Analysis Lab, Swiss Olympic Medical Center, La Tour Hospital, 1217 Meyrin, Switzerland.
Department of Sports Medicine, Swiss Olympic Medical Center, La Tour Hospital, 1217 Meyrin, Switzerland.
Biology (Basel). 2022 Oct 14;11(10):1508. doi: 10.3390/biology11101508.
Currently, there is no consensus on the best rehabilitation program to perform for nonspecific chronic low back pain (NSCLBP). However, multimodal exercises, education, and group-based sessions seem to be beneficial. We, therefore, launched such a treatment program and aimed to evaluate its effectiveness in improving patient health status. We retrospectively analyzed the records of 23 NSCLB patients who followed the MyBack program at La Tour hospital from 2020 to 2022 (25 sessions, 8 weeks). Patients were evaluated before and after intervention using pain on a visual analog scale (pVAS), Roland−Morris Disability Questionnaire (RMDQ), Pain Catastrophizing Scale (PCS), Tampa Scale of Kinesiophobia (TSK), and the EuroQol-5D-3L (EQ-5D-3L). Responder rates were calculated using minimal clinically important differences. Patients reported a significant reduction (p < 0.05) in the pVAS (5.3 ± 1.2 vs. 3.1 ± 1.6), RMDQ (8.8 ± 3.3 vs. 4.0 ± 3.7), PCS (24.5 ± 9.4 vs. 11.7 ± 7.9) and TSK (41.5 ± 9.2 vs. 32.7 ± 7.0). The EQ-5D-3L also statistically improved (score: 0.59 ± 0.14 vs. 0.73 ± 0.07; and VAS: 54.8 ± 16.8 vs. 67.0 ± 15.2). The responder rates were 78% for the pVAS and PCS, 74% for the RMDQ and TSK, and only 26% for the EQ-5D-3L. The MyBack program combining education with multimodal group exercises led to satisfactory clinical, functional, and psychosocial outcomes.
目前,对于非特异性慢性下腰痛(NSCLBP)最佳的康复方案尚无共识。然而,多模式运动、教育和小组课程似乎是有益的。因此,我们开展了这样一个治疗方案,旨在评估其对改善患者健康状况的有效性。我们回顾性分析了2020年至2022年在拉杜尔医院遵循MyBack方案的23例NSCLB患者的记录(25次课程,为期8周)。在干预前后,使用视觉模拟量表疼痛评分(pVAS)、罗兰-莫里斯残疾问卷(RMDQ)、疼痛灾难化量表(PCS)、坦帕运动恐惧量表(TSK)和欧洲五维健康量表(EQ-5D-3L)对患者进行评估。使用最小临床重要差异计算缓解率。患者报告pVAS(5.3±1.2对3.1±1.6)、RMDQ(8.8±3.3对4.0±3.7)、PCS(24.5±9.4对11.7±7.9)和TSK(41.5±9.2对32.7±7.0)有显著降低(p<0.05)。EQ-5D-3L在统计学上也有所改善(评分:0.59±0.14对0.73±0.07;VAS:54.8±16.8对67.0±15.2)。pVAS和PCS的缓解率为78%,RMDQ和TSK的缓解率为74%,而EQ-5D-3L的缓解率仅为26%。将教育与多模式小组运动相结合的MyBack方案带来了令人满意的临床、功能和心理社会结果。
Health Qual Life Outcomes. 2017-2-21
BMC Musculoskelet Disord. 2025-7-4
BMC Complement Med Ther. 2023-7-10
Biology (Basel). 2023-3-15
Cochrane Database Syst Rev. 2021-9-28
Lancet. 2021-7-3
Health Qual Life Outcomes. 2021-5-28
Neurosci Biobehav Rev. 2021-1
Br J Sports Med. 2020-11